Association between serum biomarkers and clinical stage in treatment-naïve chronic lymphocytic leukemia
Hematology, Transfusion and Cell Therapy · 2026-10 · 48 (4) · 106509
DOI: 10.1016/j.htct.2026.106509 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hematology, Transfusion and Cell Therapy, 2026-10. Verfasst von Mohammadreza Khosravifarsani und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Cancer Prevention Research Center, Isfahan University of Medical Sciences, Isfahan, Iran. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
INTRODUCTION: Chronic lymphocytic leukemia shows significant clinical heterogeneity, highlighting the need for reliable, accessible biomarkers for staging and prognosis, especially in resource-limited settings. This study evaluates the association between inflammatory and nutritional biomarkers and clinical stage in newly diagnosed, treatment-naïve patients. METHODS: A cross-sectional study enrolled 150 treatment-naïve chronic lymphocytic leukemia patients and 150 matched healthy controls at outpatient hematology clinics affiliated with Isfahan University of Medical Sciences (2024-2025). Diagnoses followed International Workshop on chronic lymphocytic leukemia 2018 criteria. Controls were confirmed healthy by peripheral blood counts, smear evaluation, and clinical examination. The Rai staging system was used. Serum biomarkers were measured at diagnosis. Statistical analysis included Analysis of Variance and Kruskal-Wallis tests, and Spearman correlation. RESULTS: Elevated ferritin, β2-microglobulin, lactate dehydrogenase and C-reactive protein levels, erythrocyte sedimentation rate, and C-reactive protein-to-albumin ratio correlated significantly with advanced Rai stages (III-IV) (p-value
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oncology, Cancer Prevention Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
- Division of General Internal Medicine, Department of Medicine, University Health Network, Toronto General Hospital, Canada.
- Division of General Internal Medicine, Department of Medicine, University Health Network, Toronto General Hospital, Canada. Electronic address: mohammad.shafiee@uhn.ca.
Zitieren
APA
Khosravifarsani, M., Parvizi, S., Mohseni, H., Tarbiat, M., Zolfaghari, B., Mostafaie, M., Hosseini, S. F., & Shafiee, M. A. (2026). Association between serum biomarkers and clinical stage in treatment-naïve chronic lymphocytic leukemia. Hematology, Transfusion and Cell Therapy, 48(4), 106509. https://doi.org/10.1016/j.htct.2026.106509
Vancouver
Khosravifarsani M, Parvizi S, Mohseni H, Tarbiat M, Zolfaghari B, Mostafaie M, et al. Association between serum biomarkers and clinical stage in treatment-naïve chronic lymphocytic leukemia. Hematology, Transfusion and Cell Therapy. 2026;48(4):106509. doi:10.1016/j.htct.2026.106509
BibTeX
@article{Khosravifarsani2026,
author = {Khosravifarsani, Mohammadreza and Parvizi, Sobhan and Mohseni, Hana and Tarbiat, Mohammad and Zolfaghari, Behnaz and Mostafaie, Mehrab and Hosseini, Sayyideh Forough and Shafiee, Mohammad Ali},
title = {Association between serum biomarkers and clinical stage in treatment-naïve chronic lymphocytic leukemia},
journal = {Hematology, Transfusion and Cell Therapy},
year = {2026},
volume = {48},
number = {4},
pages = {106509},
doi = {10.1016/j.htct.2026.106509}
}
EUVIMED